A new study offers a powerful AI-assisted method for uncovering exactly how TB drugs kill the bacteria, opening the door to smarter treatment combinations that could work faster.
Estuaries are known hotspots for biodiversity and are turbulent mixing zones where freshwater and seawater microbes confront one another. Source: Jeff Schmaltz, MODIS Land Rapid Response Team, NASA GSFC The Moderate Resolution Imaging Spectroradiometer (MODIS) aboard NASA’s Aqua satellite captured this true-color image of the Baltic Sea ...
Comparison of symbiotic bacteria to free-living relatives shows the genomic effects of host adaptation.
A new paper reveals how the activity of one of the main microbial enzymes involved in producing methane affects the isotope composition used as a fingerprint of various environmental sources.
In mice, maternal antibodies ingested in breast milk in the first week after birth help to regulate immune responses in the newborn gut, according to a new study.
A first look into the molecular defenses of archaea highlights the importance of surveying diverse microbes to discover new types of antimicrobials.
A new study offers a powerful AI-assisted method for uncovering exactly how TB drugs kill the bacteria, opening the door to smarter treatment combinations that could work faster.
Estuaries are known hotspots for biodiversity and are turbulent mixing zones where freshwater and seawater microbes confront one another. Source: Jeff Schmaltz, MODIS Land Rapid Response Team, NASA GSFC The Moderate Resolution Imaging Spectroradiometer (MODIS) aboard NASA’s Aqua satellite captured this true-color image of the Baltic Sea ...
A new paper reveals how the activity of one of the main microbial enzymes involved in producing methane affects the isotope composition used as a fingerprint of various environmental sources.
CRISPR-based therapeutics show potential to combat antimicrobial resistance (AMR) and deliver functional cures for chronic viral infections, says GlobalData, a leading data and analytics company.
Researchers unveiled a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard — and that could translate to vastly improved patient outcomes.
Flightpath Biosciences, Inc., has licensed a class of antibiotics developed at the University of Illinois Urbana-Champaign. The original antibiotic agent, lolamicin, effectively treated bacterial infections in animal models of disease without wiping out beneficial gut microbes.
With help from artificial intelligence, researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA).
Researchers have controlled the evolution of E. coli bacteria in the lab in order to dramatically increase the amount of plasmid DNA (pDNA) these modified bacteria produce. pDNA is an essential – and expensive – ingredient in many gene therapies.
Surface-enhanced Raman spectroscopy can rapidly and noninvasively detect specific bacterial species in vaginal fluid, enabling early identification of microbiome imbalances.
Mount Sinai has launched the country’s first clinical manual for treating infection-associated chronic illnesses (IACIs). This comprehensive guide, prepared by the Cohen Center for Recovery From Complex Chronic Illnesses, part of the Department of Rehabilitation and Human Performance, will help clinicians better diagnose and care for patients with conditions such ...
The Global Virus Network (GVN) has announced that it is unequivocally committed to the continued development and deployment of mRNA vaccines and the global scientific collaboration that makes such innovation possible.
Two new national Reproducibility Networks have been launched in Georgia and Ukraine with support from the TIER2 project – a step towards strengthening open, transparent, and high-quality research practices in Horizon Europe Widening participation countries.